OCI-LY3 Cell Line

Product Name	OCI-LY3 Cell Line
Cat.No	RWT-492
Size	1*10^6 cells/vial
Description	OCI-LY3 Cell Line was established from the bone marrow sample of a 52-year-old man with B-cell non-Hodgkin lymphoma (B-NHL, diffuse large B-cell lymphoma, DLBCL, stage 4B) at relapse; cells were described in the literature to be EBV-negative and lacking a classical t(8;14) translocation
Tissue	N/A
Species	Homo sapiens, human
Gender	N/A
Disease	B cell lymphoma
Biosafety Level	BSL 1. Runtogen determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services.
Morphology	round cells growing singly or in clumps in suspension
Culture Method	IMDM+ 20% FBS+0.05 mM 2-mercaptoethanol
Quality Control	OCI-LY3 Cell Line is negative for mycoplasma, bacteria, yeast, and fungi.
Shipping	Cryopreserved cells are shipped with dry ice
Storage	Upon arrival, Check all containers for leakage or breakage. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use.
Warranty	OCI-LY3 Cell Line is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product datasheet, website, and COA.
Disclaimers	Our cell line product is intended for laboratory research use only. It is not intended for any human or animal therapeutic use, any animal or human consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from Runtogen.

OCI-LY3 Cell Line

Online Inquiry

Online Inquiry